Skip to main content

Table 2 Baseline characteristics of Non-VTE and VTE groups

From: Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiectasis

 

Non-VTE (107)

VTE (10)

P

Malea

46(43)

3(30)

0.645

Age(years)b

51.4(12.5)

57.9(5.4)

0.130

BMI(kg/m2)b

23.4(3.1)

23.5(3.2)

0.969

Symptoma

  

1.000

Hemoptysis

69(64.5)

6(60)

 

No-Hemoptysis

38(35.5)

4(40)

 

Special infectiona,d

27(25.2)

5(50)

0.093

Tuberculosisa

0

1(10)

0.086

Fungusa

25(23.3)

4(40)

0.434

Pseudomonas aeruginosaa

4(3.7)

1(10)

0.366

Procedurea

  

1.000

VATS

75(70)

7(70)

 

Thoracotomy

32(30)

3(30)

 

Resected Lobesa

  

0.634

= 1 lobe

72(67.3)

6(60)

 

1–2 lobes

28(26.2)

3(30)

 

> 2 lobes

7(6.5)

1(10)

 

Operation time(min)b

161.7(56.7)

171(58.2)

0.620

Lose blood(ml)b

312.4(548.6)

153(78)

0.589

preoperative hospitalization(day)c

5(3)

7(5)

0.028

  1. BMI body mass index, SD standard deviation, IQR interquartile range
  2. an(%)
  3. bmean (SD)
  4. cmedian (IQR).VTE, venous thromboembolism; VATS, video-assisted thoracoscopic surgery
  5. dSpecial infection: including tuberculosis, fungus, and Pseudomonas aeruginosa